Berry Consultants is delighted to announce that FACTS 6.1 is ready for release! Building on FACTS 6, FACTS 6.1 adds two new Dose Escalation simulation
This week, we (Melanie Quintana, Roger Lewis, and myself) have an article in JAMA entitled “Bayesian Analysis : Use of Prior Information in Clinical Trials”
Platform trials can efficiently evaluate multiple treatments simultaneously and employ unique statistical analyses to define best therapies. They are a natural extension of Bayesian adaptive
Duke Clinical Research Institute is announcing a public meeting to disseminate and discuss the results of an NIH-funded project (known as ADAPT) to design a more
Berry Consultants is once again a sponsor and will have significant presence at this year's Joint Statistical Meetings (JSM) held on July 30 – August 4 in
Today, The Clinical Trials Transformation Initiative (CTTI), released recommendations and best practices for the use of Data Monitoring Committees (DMCs). Congratulations to Berry Consultants team
Berry Consultants releases three new videos as part of a new video series on adaptive designs. The videos released this week are: –DSMBs for Adaptive Trials
Berry Consultants is a sponsor for this year's Joint Statistical Meetings (JSM) held on August 8 – 13 in Seattle, Washington. In addition, Berry Consultants
The House Energy and Commerce Committee yesterday released an initial discussion document outlining some specific proposals with the common goal of accelerating the pace of
35 partners from industry and academia to join European research initiative for the prevention of Alzheimer’s dementia · The European Prevention of Alzheimer’s dementia (EPAD) Initiative
© 2012-2021 All rights reserved - Berry Consultants